Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_4
4
67%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 44 (66.7%)
N/A1 (16.7%)

Trials by Status

withdrawn117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_4

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

NCT01481883
completednot_applicable

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

NCT02982083
completedphase_4

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

NCT02354001
completedphase_4

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

NCT03418831
withdrawnphase_2

Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

NCT03147196
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01481883Phase 4

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Completed
NCT02982083Not Applicable

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Completed
NCT02354001Phase 4

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Completed
NCT03418831Phase 4

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

Completed
NCT03147196Phase 2

Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Withdrawn
NCT00361543Phase 4

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6